ArticleFrontiers in oncology2019

MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells.

Fang-I Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.